Synchrony Financial

SYFNYSEUSD

THESIS ALERT

Email me when the SYF thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$72.02
+$0.32 (+0.45%)Today 1M −1.07%
After hours$72.020.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$71.70
Prior regular-session close from the quote source.
$70.46–$72.92
Regular-session low and high so far today.
4.8M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Jan 26 projected
Projected for 2027-01-26 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$63.08–$88.77
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own SYF if underwriting and partner relationships hold, low valuation plus steady buybacks/dividends can produce attractive shareholder returns.

SYF price history

Latest price$72.02Today+$0.32 (+0.45%)
SYF -2.83%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Synchrony’s embedded retailer and co-brand partnerships are the causal engine that sustain loan originations and high-yielding consumer credit flows, keeping net interest income and revenue stable even as competition rises.StrengtheningMateriality: High

    Revenue rose from $14.72B (2021) to $18.99B (2025), showing growth in originations / interest income over multiple years (revenue, annual, FY 2021 vs FY 2025). If partnerships keep sending loans, revenue/NII stay stable and EPS and buybacks are funded; if partners leave or shrink programs, originations and NII fall before margins recover.

    Watch: A major retail partner terminating or reissuing its private-label/co-brand card with a different issuer (merchant/partner loss).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue rose from $14.72B (2021) to $18.99B (2025), showing growth in originations / interest income over multiple years (revenue, annual.

    Open source ↗
  • Stable, high operating cash flow and sizeable cash balances give Synchrony the liquidity to fund loan growth, meet funding needs in stress, and sustain buybacks/dividends that compound EPS.StrengtheningMateriality: High

    Operating cash flow has been large and stable: $6.694B (2022) -> $8.593B (2023) -> $9.848B (2024) -> $9.851B (2025) (operating_cash_flow, annual). If cash flow and liquidity remain strong, the company can grow the loan book and return capital without issuing equity; if funding costs spike or cash flow falls, growth and buybacks will be curtailed, hurting EPS.

    Watch: A wholesale funding market freeze or sharp increase in deposit rates that forces the company to replace low-cost funding at materially higher rates (funding shock).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow has been large and stable: $6.694B (2022) -> $8.593B (2023) -> $9.848B (2024) -> $9.851B (2025) (operating_cash_flow.

    Open source ↗
  • Profitability depends on maintained underwriting discipline and reserve adequacy: if credit performance (charge-offs, delinquencies) stays within management expectations, net income and margins remain intact; if losses spike, net income and EPS fall quickly.HoldingMateriality: Medium

    Net income recovered from $2.238B (2023) to $3.499B (2024) and $3.552B (2025), implying reserves/underwriting managed through the recent cycle (net_income, annual). Credit losses are the direct causal route to margin compression and EPS decline; investors must see early deterioration in credit metrics to anticipate earnings trouble.

    Watch: Macro shock (recession, sharp unemployment increase) producing higher-than-expected consumer charge-offs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Net income recovered from $2.238B (2023) to $3.499B (2024) and $3.552B (2025), implying reserves/underwriting managed through the recent cycle (net_income.

    Open source ↗
  • Synchrony’s large asset base and liability diversification create a funding scale advantage that lowers blended funding costs and allows it to win and price large merchant programs more profitably than smaller entrants.StrengtheningMateriality: Medium

    Assets grew from $95.748B (2021) to $119.095B (2025), indicating scale expansion (assets, period-end). Scale in assets/funding lowers marginal funding cost and supports NII and competitive bids for partner programs; loss of scale or rising funded cost reduces NII and margins before revenue cuts are seen.

    Watch: A funded asset runoff or aggressive securitization/portfolio sales that shrinks the balance sheet and removes scale benefits.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Assets grew from $95.748B (2021) to $119.095B (2025), indicating scale expansion (assets, period-end).

    Open source ↗
  • Given the current low multiples, the stock’s upside is driven primarily by continued EPS expansion (through NII growth, contained losses, and buybacks); failure to sustain EPS growth will likely result in little multiple expansion and underperformance versus peers.StrengtheningMateriality: Medium

    Diluted EPS rose from $5.19 (2023) to $8.55 (2024) and $9.28 (2025), demonstrating the company can grow EPS via improved earnings and returns of capital (eps_diluted, annual). EPS is the observable the market uses to re-rate the bank; if EPS growth stalls, the cheap valuation offers limited protection.

    Watch: Management halts buybacks or raises equity (dilution) because of capital or funding stress.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Diluted EPS rose from $5.19 (2023) to $8.55 (2024) and $9.28 (2025), demonstrating the company can grow EPS via improved.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Synchrony’s embedded retailer and co-brand partnerships are the causal engine that sustain loan originations and high-yielding consumer credit flows, keeping net interest income and revenue stable even as competition rises. If partnerships keep sending loans, revenue/NII stay stable and EPS and buybacks are funded; if partners leave or shrink programs, originations and NII fall before margins recover.

Stable, high operating cash flow and sizeable cash balances give Synchrony the liquidity to fund loan growth, meet funding needs in stress, and sustain buybacks/dividends that compound EPS. If cash flow and liquidity remain strong, the company can grow the loan book and return capital without issuing equity; if funding costs spike or cash flow falls, growth and buybacks will be curtailed, hurting EPS.

Profitability depends on maintained underwriting discipline and reserve adequacy: if credit performance (charge-offs, delinquencies) stays within management expectations, net income and margins remain intact; if losses spike, net income and EPS fall quickly. Credit losses are the direct causal route to margin compression and EPS decline; investors must see early deterioration in credit metrics to anticipate earnings trouble.

Synchrony’s large asset base and liability diversification create a funding scale advantage that lowers blended funding costs and allows it to win and price large merchant programs more profitably than smaller entrants. Scale in assets/funding lowers marginal funding cost and supports NII and competitive bids for partner programs; loss of scale or rising funded cost reduces NII and margins before revenue cuts are seen.

Given the current low multiples, the stock’s upside is driven primarily by continued EPS expansion (through NII growth, contained losses, and buybacks); failure to sustain EPS growth will likely result in little multiple expansion and underperformance versus peers. EPS is the observable the market uses to re-rate the bank; if EPS growth stalls, the cheap valuation offers limited protection.

All standing thesis claims
Original report summary

underwriting and partner relationships hold, low valuation plus steady buybacks/dividends can produce attractive shareholder returns.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Synchrony Financial

Where the evidence on Synchrony Financial stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.

Bull case: what the evidence supports

  • Synchrony’s embedded retailer and co-brand partnerships are the causal engine that sustain loan originations and high-yielding consumer credit flows, keeping net interest income and revenue stable even as competition rises.

    sec.gov ↗

  • Stable, high operating cash flow and sizeable cash balances give Synchrony the liquidity to fund loan growth, meet funding needs in stress, and sustain buybacks/dividends that compound EPS.

    sec.gov ↗

  • Profitability depends on maintained underwriting discipline and reserve adequacy: if credit performance (charge-offs, delinquencies) stays within management expectations, net income and margins remain intact; if losses spike, net income and EPS fall quickly.

    sec.gov ↗

  • Synchrony’s large asset base and liability diversification create a funding scale advantage that lowers blended funding costs and allows it to win and price large merchant programs more profitably than smaller entrants.

    sec.gov ↗

  • Given the current low multiples, the stock’s upside is driven primarily by continued EPS expansion (through NII growth, contained losses, and buybacks); failure to sustain EPS growth will likely result in little multiple expansion and underperformance versus peers.

    sec.gov ↗

Bear case: what would count against it

  • A major retail partner terminating or reissuing its private-label/co-brand card with a different issuer (merchant/partner loss).

    sec.gov ↗

  • A wholesale funding market freeze or sharp increase in deposit rates that forces the company to replace low-cost funding at materially higher rates (funding shock).

    sec.gov ↗

  • Macro shock (recession, sharp unemployment increase) producing higher-than-expected consumer charge-offs.

    sec.gov ↗

Thesis-Break Engine

What has broken in Synchrony Financial’s thesis

Each break OptimistFi flagged on Synchrony Financial, dated — with what has historically followed the same kind of break across the market, not a forecast for Synchrony Financial.

peers+17%-20%-1%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -1% path vs comparable companies over six months, inside the middle-half range (+17% to -20%). A base rate, not a forecast.
  • Revenue decline

    Across all companies, this kind of break has happened 8,727 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 37% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Regulation FD disclosure.

    Synchrony Financial filed an SEC 8-K on 2026-10-20: Regulation FD disclosure. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Synchrony Financial filed an SEC 8-K on 2026-10-20: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Regulation FD disclosure.

    Synchrony Financial filed an SEC 8-K on 2026-09-14: Regulation FD disclosure. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A major retail partner terminating or reissuing its private-label/co-brand card with a different issuer (merchant/partner loss).
  • A wholesale funding market freeze or sharp increase in deposit rates that forces the company to replace low-cost funding at materially higher rates (funding shock).
  • Macro shock (recession, sharp unemployment increase) producing higher-than-expected consumer charge-offs.
  • A funded asset runoff or aggressive securitization/portfolio sales that shrinks the balance sheet and removes scale benefits.
  • Management halts buybacks or raises equity (dilution) because of capital or funding stress.

SYF news

Loading headlines…

Financial statements

SYF income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

SYF: quick answers

When does Synchrony Financial (SYF) report earnings next?
Synchrony Financial's next results are projected for January 26, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 20, 2026. Earnings calendar
What is SYF's short interest?
As of October 30, 2026, 17.3M SYF shares were sold short, 5.56% of its shares outstanding, up 5.3% from the count before. At the stock's average daily volume that is 4.8 days to cover. FINRA publishes the count twice a month. SYF short interest history
Have members of Congress traded SYF?
52 trades in SYF have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed SYF trade
Which well-known investors own SYF?
1 of the 37 well-known funds tracked here reported SYF shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios

SYF in well-known investors’ portfolios

1 of 37 funds reported SYF shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.05%$11.7MNewQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.